Connection

Mark George to Depressive Disorder, Major

Back to Details
This is a "connection" page, showing publications Mark George has written about Depressive Disorder, Major.
Mark George
Connection Strength
7.321
Depressive Disorder, Major
  1. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021 Nov-Dec; 14(6):1508-1510.
    View in: PubMed
    Score: 0.555
  2. Treatment of Adults with Autism and Major Depressive Disorder Using Transcranial Magnetic Stimulation: An Open Label Pilot Study. Autism Res. 2020 03; 13(3):346-351.
    View in: PubMed
    Score: 0.494
  3. Transcranial Magnetic Stimulation (TMS) in the Elderly. Curr Psychiatry Rep. 2018 02 10; 20(1):6.
    View in: PubMed
    Score: 0.432
  4. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7.
    View in: PubMed
    Score: 0.371
  5. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015 Jul-Aug; 8(4):787-94.
    View in: PubMed
    Score: 0.358
  6. Brain stimulation treatments for depression. World J Biol Psychiatry. 2014 Feb; 15(2):167-8.
    View in: PubMed
    Score: 0.327
  7. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial. Brain Stimul. 2013 Nov; 6(6):925-8.
    View in: PubMed
    Score: 0.312
  8. Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression. J ECT. 2011 Mar; 27(1):5-10.
    View in: PubMed
    Score: 0.267
  9. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011 Mar; 27(1):18-25.
    View in: PubMed
    Score: 0.267
  10. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May; 67(5):507-16.
    View in: PubMed
    Score: 0.252
  11. Feasibility of simultaneous cognitive behavioral therapy and left prefrontal rTMS for treatment resistant depression. Brain Stimul. 2010 Oct; 3(4):207-10.
    View in: PubMed
    Score: 0.251
  12. Brain stimulation, revolutions, and the shifting time domain of depression. Biol Psychiatry. 2008 Sep 15; 64(6):447-8.
    View in: PubMed
    Score: 0.225
  13. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009 Jan; 34(2):522-34.
    View in: PubMed
    Score: 0.224
  14. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008 Mar; 69(3):441-51.
    View in: PubMed
    Score: 0.217
  15. Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next? Curr Psychiatry Rep. 2006 Dec; 8(6):445-51.
    View in: PubMed
    Score: 0.199
  16. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005 Sep; 66(9):1097-104.
    View in: PubMed
    Score: 0.182
  17. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004 May 01; 55(9):882-90.
    View in: PubMed
    Score: 0.166
  18. Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry. 2004 Apr 15; 55(8):816-25.
    View in: PubMed
    Score: 0.166
  19. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56.
    View in: PubMed
    Score: 0.163
  20. Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression. Cogn Behav Neurol. 2003 Jun; 16(2):128-35.
    View in: PubMed
    Score: 0.156
  21. Daily prefrontal closed-loop repetitive transcranial magnetic stimulation (rTMS) produces progressive EEG quasi-alpha phase entrainment in depressed adults. Brain Stimul. 2022 Mar-Apr; 15(2):458-471.
    View in: PubMed
    Score: 0.143
  22. Ruminative reflection is associated with anticorrelations between the orbitofrontal cortex and the default mode network in depression: implications for repetitive transcranial magnetic stimulation. Brain Imaging Behav. 2022 Jun; 16(3):1186-1195.
    View in: PubMed
    Score: 0.141
  23. The Effects of Focal Electrically Administered Seizure Therapy Compared With Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy on Suicidal Ideation: A 2-Site Clinical Trial. J ECT. 2021 12 01; 37(4):256-262.
    View in: PubMed
    Score: 0.141
  24. Prefrontal transcranial magnetic stimulation for depression in US military veterans - A naturalistic cohort study in the veterans health administration. J Affect Disord. 2022 01 15; 297:671-678.
    View in: PubMed
    Score: 0.140
  25. The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder. Aust N Z J Psychiatry. 2022 07; 56(7):745-751.
    View in: PubMed
    Score: 0.138
  26. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression. BMC Psychiatry. 2021 01 13; 21(1):35.
    View in: PubMed
    Score: 0.132
  27. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. J Clin Psychiatry. 2018 Jan/Feb; 79(1).
    View in: PubMed
    Score: 0.107
  28. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016 May-Jun; 9(3):336-346.
    View in: PubMed
    Score: 0.095
  29. Resting-state functional connectivity of antero-medial prefrontal cortex sub-regions in major depression and relationship to emotional intelligence. Int J Neuropsychopharmacol. 2015 Mar 05; 18(6).
    View in: PubMed
    Score: 0.088
  30. Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders. J Affect Disord. 2014 Oct; 168:243-53.
    View in: PubMed
    Score: 0.084
  31. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010 Jan 15; 67(2):101-9.
    View in: PubMed
    Score: 0.062
  32. Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial". Biol Psychiatry. 2010 Jan 15; 67(2):e15-7.
    View in: PubMed
    Score: 0.062
  33. The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold. Brain Stimul. 2009 Jul; 2(3):163-7.
    View in: PubMed
    Score: 0.059
  34. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.055
  35. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007 Dec 01; 62(11):1208-16.
    View in: PubMed
    Score: 0.052
  36. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 2006 Jul; 31(7):1345-55.
    View in: PubMed
    Score: 0.048
  37. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res. 2006 Mar 31; 146(2):179-84.
    View in: PubMed
    Score: 0.047
  38. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54.
    View in: PubMed
    Score: 0.046
  39. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectr. 2004 Jun; 9(6):476-82.
    View in: PubMed
    Score: 0.042
  40. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. Nat Hum Behav. 2021 12; 5(12):1707-1716.
    View in: PubMed
    Score: 0.034
  41. Reward circuit DBS improves Parkinson's gait along with severe depression and OCD. Neurocase. 2016; 22(2):201-4.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.